NEEMA DAVE: Open Payments
NPI 1407354491 · LILLINGTON, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$721 in 36 payments from 13 companies in 2025. Trend: 2023 $1,026 · 2024 $1,650 · 2025 $721
Food & beverage: $643Education: $78
| Company | Payments | Amount |
|---|---|---|
| SCILEX PHARMACEUTICALS INC. | 13 | $160 |
| Teva Pharmaceuticals USA, Inc. | 5 | $154 |
| ABBVIE INC. | 4 | $91 |
| VERTEX PHARMACEUTICALS INCORPORATED | 1 | $61 |
| Neurocrine BioSciences, Inc. | 2 | $47 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $40 |
| Biogen, Inc. | 2 | $39 |
| Neurelis, Inc. | 2 | $36 |
| Valinor Pharma, LLC | 1 | $22 |
| Collegium Pharmaceutical, Inc. | 1 | $21 |
Products named: ZTLido, QULIPTA, JOURNAVX, AUSTEDO XR, INGREZZA, RELISTOR, VUMERITY, VALTOCO.
Industry payments across NC — which companies pay providers there.
